Stryker (SYK) Interest Expenses (2025 - 2026)
Stryker (SYK) reported Interest Expenses of $148.0 million for Q1 2026, up 8.03% year-over-year from $137.0 million in Q1 2025, and up 8.03% on a QoQ basis from $137.0 million in Q1 2025.
Stryker (SYK) has 2 years of Interest Expenses data on file, last reported at $148.0 million in Q1 2026.
- Quarterly Interest Expenses rose 8.03% year-over-year to $148.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $148.0 million (up 8.03% YoY) and the FY2025 annual result came in at $607.0 million, up 48.41% from the prior year.
- Interest Expenses grew to $148.0 million in Q1 2026 per SYK's latest filing, from $137.0 million in the prior quarter.
- Across five years, Interest Expenses topped out at $148.0 million in Q1 2026 and bottomed at $137.0 million in Q1 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 174.00 Mn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 148.00 Mn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 181.00 Mn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 90.00 Mn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -97.17 Mn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 96.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 15.10 Mn |
| 10 | Zimmer Biomet Holdings | 16.17 Bn | 15.75 Bn | 1.51 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 148.00 Mn |
| Mar 31, 2026 | 148.00 Mn |
| Mar 31, 2025 | 137.00 Mn |
| Mar 31, 2025 | 137.00 Mn |